PMM2 and angioedema: However, we must remember that most PMM2-CDG patients have not been exposed to the triggering factors that cause angioedema in carriers of the p.Thr309Lys mutation (pregnancy, oral contraceptives...) [31], and on the other hand that marked edemas were already reported in CDG patients [32–36].